| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 1031184
[patent_doc_number] => 06878736
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-04-12
[patent_title] => 'Histamine H3 receptor ligands'
[patent_app_type] => utility
[patent_app_number] => 09/622544
[patent_app_country] => US
[patent_app_date] => 1999-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 17
[patent_no_of_words] => 41299
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/878/06878736.pdf
[firstpage_image] =>[orig_patent_app_number] => 09622544
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/622544 | Histamine H3 receptor ligands | Feb 14, 1999 | Issued |
Array
(
[id] => 4385520
[patent_doc_number] => 06277984
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Monomethine cyanines rigidized by a two-carbon chain'
[patent_app_type] => 1
[patent_app_number] => 9/249537
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10741
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277984.pdf
[firstpage_image] =>[orig_patent_app_number] => 249537
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249537 | Monomethine cyanines rigidized by a two-carbon chain | Feb 10, 1999 | Issued |
Array
(
[id] => 6861692
[patent_doc_number] => 20030092700
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'BENZAZEPINE DERIVATIVES, MEDICAMENTS CONTAINING THE SAME AND THEIR USE TO PREPARE MEDICAMENTS'
[patent_app_type] => new
[patent_app_number] => 09/242339
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37056
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092700.pdf
[firstpage_image] =>[orig_patent_app_number] => 09242339
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/242339 | Benzazepine derivatives, medicaments containing the same and their use to prepare medicaments | Feb 10, 1999 | Issued |
| 09/244179 | ARYLTHIOPHENE VASOPRESSIN AGONISTS | Feb 3, 1999 | Pending |
| 09/244680 | TRICYCLIC PYRIDINE N-OXIDE VASOPRESSIN AGONISTS | Feb 3, 1999 | Pending |
| 09/244180 | PYRROLOBENZODIAZEPINE CARBOXYAMIDE VASOPRESSIN AGONISTS | Feb 3, 1999 | Pending |
| 09/237058 | 2,3,4,5-TETRAHYDRO-1H-[1,4]-BENZODIAZEPINE-3-HYDROXYAMIC ACIDS | Jan 25, 1999 | Abandoned |
Array
(
[id] => 1602986
[patent_doc_number] => 06433165
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Chemokine receptor antagonists and methods of use therefor'
[patent_app_type] => B1
[patent_app_number] => 09/234868
[patent_app_country] => US
[patent_app_date] => 1999-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 11606
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 531
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/433/06433165.pdf
[firstpage_image] =>[orig_patent_app_number] => 09234868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/234868 | Chemokine receptor antagonists and methods of use therefor | Jan 20, 1999 | Issued |
Array
(
[id] => 4171138
[patent_doc_number] => 06140322
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-10-31
[patent_title] => 'Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase'
[patent_app_type] => 1
[patent_app_number] => 9/233476
[patent_app_country] => US
[patent_app_date] => 1999-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25326
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/140/06140322.pdf
[firstpage_image] =>[orig_patent_app_number] => 233476
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/233476 | Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase | Jan 19, 1999 | Issued |
Array
(
[id] => 4383620
[patent_doc_number] => 06262068
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'Lactam derivatives as antiarrhythmic agents'
[patent_app_type] => 1
[patent_app_number] => 9/231678
[patent_app_country] => US
[patent_app_date] => 1999-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8419
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262068.pdf
[firstpage_image] =>[orig_patent_app_number] => 231678
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/231678 | Lactam derivatives as antiarrhythmic agents | Jan 13, 1999 | Issued |
Array
(
[id] => 1451403
[patent_doc_number] => 06455694
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'Antibiotics RK-1061 and process for preparing the same'
[patent_app_type] => B1
[patent_app_number] => 09/171787
[patent_app_country] => US
[patent_app_date] => 1999-01-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 8276
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455694.pdf
[firstpage_image] =>[orig_patent_app_number] => 09171787
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171787 | Antibiotics RK-1061 and process for preparing the same | Jan 11, 1999 | Issued |
| 09/224549 | N-CARBOXYMETHYL SUBSTITUTED BENZOLACTAMS AS INHIBITORS OF MATRIX METALLOPROTEINASE | Dec 30, 1998 | Pending |
| 09/224428 | HETEROCYCLIC PRENYL TRANSFERASE INHIBITORS | Dec 30, 1998 | Abandoned |
| 09/224457 | 1-CARBOXYMETHYL-2-OXO-AZEPAN DERIVATIVES USEFUL AS SELECTIVE INHIBITORS OF MMP-12 | Dec 30, 1998 | Pending |
| 09/218921 | HETEROCYCLO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS CYCLOOXYGENASE-2 AND 5-LIPOXYGENASE INHIBITORS | Dec 21, 1998 | Abandoned |
Array
(
[id] => 1441198
[patent_doc_number] => 06335329
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-01
[patent_title] => 'Carboxylic acid substituted heterocycles, derivatives thereof and methods of use'
[patent_app_type] => B1
[patent_app_number] => 09/213031
[patent_app_country] => US
[patent_app_date] => 1998-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20274
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 985
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/335/06335329.pdf
[firstpage_image] =>[orig_patent_app_number] => 09213031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/213031 | Carboxylic acid substituted heterocycles, derivatives thereof and methods of use | Dec 15, 1998 | Issued |
Array
(
[id] => 1565423
[patent_doc_number] => 06339083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Multiheterocyclic pharmAceuticals'
[patent_app_type] => B1
[patent_app_number] => 09/211274
[patent_app_country] => US
[patent_app_date] => 1998-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5073
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09211274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/211274 | Multiheterocyclic pharmAceuticals | Dec 13, 1998 | Issued |
Array
(
[id] => 1433462
[patent_doc_number] => 06340752
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-22
[patent_title] => 'Deprotection and recrystallization processes'
[patent_app_type] => B1
[patent_app_number] => 09/208135
[patent_app_country] => US
[patent_app_date] => 1998-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8310
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 581
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/340/06340752.pdf
[firstpage_image] =>[orig_patent_app_number] => 09208135
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/208135 | Deprotection and recrystallization processes | Dec 8, 1998 | Issued |
Array
(
[id] => 3928717
[patent_doc_number] => 05952493
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-14
[patent_title] => 'Method of purifying .epsilon.-caprolactam'
[patent_app_type] => 1
[patent_app_number] => 9/202094
[patent_app_country] => US
[patent_app_date] => 1998-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1050
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/952/05952493.pdf
[firstpage_image] =>[orig_patent_app_number] => 202094
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/202094 | Method of purifying .epsilon.-caprolactam | Dec 8, 1998 | Issued |
Array
(
[id] => 4274173
[patent_doc_number] => 06245907
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-12
[patent_title] => 'Process for producing a high purity caprolactam'
[patent_app_type] => 1
[patent_app_number] => 9/205900
[patent_app_country] => US
[patent_app_date] => 1998-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4018
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/245/06245907.pdf
[firstpage_image] =>[orig_patent_app_number] => 205900
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/205900 | Process for producing a high purity caprolactam | Dec 3, 1998 | Issued |
